External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CTOS 2022

-
Coming soon
01:00 PM
Duration 8mins Vancouver, Canada
Updated efficacy and safety of entrectinib▼in patients with ntrk fusion-positive sarcomas
Loong H, Medina L, Tinoco G, Garrido-Laguna I, Goto K, Steuer C, Liu S Osborne S, Bordogna W, Heinzmann S, Zeuner H, Demetri G

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar